• CCK-8s Induces ANP Secretion via NOX4–PGC-1α–PPAR Pathways

  2026-07-03

  This study elucidates how sulfated cholecystokinin octapeptide (CCK-8s) directly stimulates atrial natriuretic peptide (ANP) secretion in isolated beating rat atria via a defined NOX4–PGC-1α–PPARα/γ signaling cascade. The findings clarify the molecular interplay between cardiac peptide release, oxidative signaling, and anti-inflammatory mechanisms, contributing valuable insight for cardiovascular and inflammation-focused research.

• Bufalin as a Cardiotonics Tool: Protocols and Innovations in

  2026-07-03

  Bufalin, a cardiotonic steroid from APExBIO, is redefining cancer research by enabling targeted apoptosis and molecular degradation routes in challenging oncology models. This guide delivers actionable protocols, troubleshooting insights, and a translational bridge to clinical relevance, drawing directly from recent advances in triple-negative breast cancer workflows.

• SD 169 (indole-5-carboxamide): Redefining p38 MAPK Control

  2026-07-02

  This thought-leadership article explores how SD 169 (indole-5-carboxamide), a selective ATP-competitive inhibitor, is reshaping translational research targeting p38 MAPK. We provide mechanistic insights, evidence-based experimental guidance, and a strategic outlook for researchers navigating inflammation, type 1 diabetes, and neuroregeneration. By synthesizing recent findings on dual-action inhibition, we map new opportunities for precision pathway modulation and robust disease modeling, highlighting how SD 169 advances beyond conventional inhibitors and standard product literature.

• PPM-18 in Translational Sepsis and Inflammation Research

  2026-07-02

  PPM-18, a potent iNOS expression inhibitor, enables precise modulation of NF-κB signaling for advanced inflammation and sepsis models. This article delivers practical protocols, real-world troubleshooting, and comparative insight for researchers leveraging this anti-inflammatory naphthoquinone derivative from APExBIO.

• Applied Use of Glycogen Colorimetric Assay Kit II in Enduran

  2026-07-01

  The Glycogen Colorimetric Assay Kit II offers rapid, interference-resistant quantification of glycogen across complex biological matrices, empowering high-throughput metabolic and exercise adaptation studies. This article details workflow optimization, practical troubleshooting, and new insights from circadian exercise research to help scientists achieve reliable glycogen measurements.

• VX-765: Selective Caspase-1 Inhibition and Inflammation Cont

  2026-07-01

  VX-765 is a potent, selective, orally bioavailable caspase-1 inhibitor. It blocks IL-1β and IL-18 release, suppresses pyroptosis in macrophages, and demonstrates efficacy in preclinical models of inflammation. Its specificity and pharmacokinetics make it a gold standard for dissecting inflammasome-mediated cell death.

• Translational Fidelity of mRNA with Pseudouridine Modificati

  2026-06-30

  The reference study systematically evaluates how N1-methylpseudouridine, a key modification in COVID-19 mRNA vaccines, impacts translation fidelity and protein expression. Its findings clarify that this modified nucleotide does not introduce miscoding or instability, supporting the safe design of advanced mRNA therapeutics.

• Functional Genomic Screens Reveal Drug-Induced Cell Death Me

  2026-06-30

  Honeywell et al. introduce MEDUSA, a model-assisted method to disentangle growth and death rates in functional genomic screens, enabling precise identification of genetic regulators of drug-induced cell death. This approach clarifies confounding factors in pooled chemo-genetic profiling and illuminates non-apoptotic death mechanisms, with implications for optimizing targeted therapies and mechanistic studies of cell death.

• VX-765: Selective Caspase-1 Inhibitor Empowering Inflammatio

  2026-06-29

  VX-765 enables precise, reproducible inhibition of caspase-1-mediated inflammation and pyroptosis, providing advanced specificity in cell and animal models. Its selectivity for IL-1β and IL-18 release, coupled with robust solubility and bioavailability, makes it the preferred tool for dissecting complex inflammatory mechanisms.

• Hepatic sEH Drives Osteoclastogenesis via Nrf2 Suppression i

  2026-06-29

  A recent study uncovers that hepatic soluble epoxide hydrolase (sEH) promotes osteoclast differentiation by suppressing Nrf2 signaling, thus fueling redox imbalance and bone loss in osteoporosis. This mechanism defines a novel liver-bone axis and opens new avenues for targeting lipid metabolism and oxidative stress in chronic inflammation research.

• Network Medicine Uncovers Apigenin’s Multi-Targeted Neuropro

  2026-06-28

  A recent network pharmacology study systematically identified Apigenin as a leading flavonoid modulator of Alzheimer’s disease pathways. By integrating in silico network proximity analysis with cellular and molecular validation, the research highlights Apigenin’s direct effects on apoptosis, inflammation, and neuronal resilience—providing a rigorous framework for translational neuroprotective strategies.

• Oridonin Mitigates TAA-Induced Bone Loss via MAPK/NF-κB Modu

  2026-06-27

  This study reveals that oridonin protects against thioacetamide-induced bone loss by inhibiting osteoclastogenesis through the MAPK/NF-κB pathway and promoting osteoblast differentiation via the BMP-2/RUNX2 pathway. These findings provide mechanistic insight into dual-action therapeutic strategies for osteoporosis and highlight the translational value of targeting inflammatory signaling in bone disease.

• Hesperadin: Aurora B Kinase Inhibitor for Mitotic Checkpoint

  2026-06-26

  Hesperadin stands out as a selective Aurora B kinase inhibitor, enabling high-precision dissection of mitotic progression, spindle assembly checkpoint signaling, and chromosome segregation. This guide delivers actionable workflows, protocol refinements, and troubleshooting strategies for cancer research and advanced cell cycle studies.

• Isoproterenol Sulfate Dihydrate: Beta-Adrenergic Signaling i

  2026-06-26

  Isoproterenol sulfate dihydrate is a high-purity, non-selective beta-adrenergic agonist pivotal for dissecting cardiac GPCR signaling pathways. Its robust solubility and validated receptor activity make it a gold-standard tool for modeling neuro-cardiac interactions and pacemaker maturation in human assembloid systems. Rigorous product verification and workflow guidelines ensure reproducible results for cardiovascular research.

• Transcription Termination Mitigates DNA Damage After WEE1 In

  2026-06-25

  This study reveals that transcription termination is crucial for limiting DNA damage arising from transcription-replication conflicts following WEE1 inhibition in cancer cells. The findings provide mechanistic insight into genome integrity regulation and have implications for designing combinatorial cancer therapies targeting replication stress.

16608 records 1/1108 page Next 12345 下5页 Last page